QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 170 Cr.
- Current Price ₹ 94.0
- High / Low ₹ 140 / 71.5
- Stock P/E 15.8
- Book Value ₹ 45.6
- Dividend Yield 0.53 %
- ROCE 14.6 %
- ROE 12.5 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 130 days to 103 days
Cons
- Company has a low return on equity of 12.4% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|
0 | 52 | 73 | 122 | 146 | 104 | 122 | 145 | 157 | |
0 | 47 | 63 | 105 | 130 | 93 | 104 | 122 | 132 | |
Operating Profit | 0 | 5 | 10 | 17 | 17 | 11 | 18 | 23 | 25 |
OPM % | 12% | 9% | 13% | 14% | 11% | 11% | 15% | 16% | 16% |
0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | |
Interest | 0 | 0 | 1 | 1 | 2 | 2 | 3 | 6 | 7 |
Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 3 | 3 | 3 |
Profit before tax | 0 | 4 | 9 | 15 | 14 | 9 | 12 | 14 | 15 |
Tax % | 0% | 30% | 28% | 27% | 26% | 27% | 26% | 28% | |
0 | 3 | 6 | 11 | 11 | 6 | 9 | 10 | 11 | |
EPS in Rs | 19.15 | 26.63 | 26.07 | 3.31 | 4.66 | 5.40 | 5.55 | ||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 0% |
TTM: | 24% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 2% |
TTM: | 20% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -26% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 12% |
Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 3 | 4 | 4 | 18 | 18 | 18 |
Reserves | 0 | 3 | 6 | 17 | 27 | 53 | 61 | 70 |
0 | 5 | 12 | 20 | 32 | 26 | 35 | 78 | |
5 | 10 | 12 | 20 | 19 | 22 | 22 | 23 | |
Total Liabilities | 5 | 18 | 33 | 60 | 82 | 118 | 135 | 189 |
0 | 0 | 3 | 10 | 8 | 25 | 24 | 25 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 48 |
5 | 18 | 30 | 50 | 75 | 91 | 108 | 115 | |
Total Assets | 5 | 18 | 33 | 60 | 82 | 118 | 135 | 189 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
0 | 0 | 4 | 2 | -2 | -8 | 1 | 23 | |
0 | -0 | -4 | -8 | 2 | -25 | -3 | -49 | |
0 | 0 | 0 | 7 | 0 | 32 | 0 | 26 | |
Net Cash Flow | 0 | 0 | 1 | 1 | 1 | -1 | -1 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 411 | 56 | 56 | 69 | 105 | 137 | 124 | 104 |
Inventory Days | 22,891 | 76 | 108 | 82 | 80 | 140 | 172 | 176 |
Days Payable | 26,124 | 75 | 78 | 73 | 56 | 91 | 90 | 74 |
Cash Conversion Cycle | -2,822 | 58 | 86 | 77 | 129 | 187 | 205 | 206 |
Working Capital Days | -91 | 20 | 27 | 28 | 57 | 138 | 148 | 103 |
ROCE % | 121% | 65% | 54% | 30% | 14% | 15% | 15% |
Documents
Announcements
-
General Updates
3 September 2025 - Board approved rights issue of 1,487,500 shares at ₹81 each (≈₹12.05 crore); record date Sep 4, 2025.
-
Appointment
29 August 2025 - Board approved Maharshi Ganatra & Associates as secretarial auditors for FY2025-26 to FY2029-30, subject to shareholder approval.
-
Rights Issue
29 August 2025 - Board approved rights issue of 1,487,500 shares at ₹81 (₹12,04,87,500); record date Sep 4; opens Sep 12.
-
Record Date
29 August 2025 - Record date set September 4, 2025 for QMS Medical's rights issue.
-
Rights Issue
29 August 2025 - Rights issue: 14,87,500 shares @₹81 (₹12,04,87,500); Record Sep 4; Issue Sep12–22; AGM Sep29.
Annual reports
Concalls
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.